Discovery shows existing drugs can treat virus
A team of researchers from Florida State University, Johns Hopkins University and the National Institutes of Health has found existing drug compounds that can both stop Zika from replicating in the body and from damaging the crucial fetal brain cells that lead to birth defects in newborns.
One of the drugs is already on the market as a treatment for tapeworm.
“We focused on compounds that have the shortest path to clinical use,” said FSU Professor of Biological Science Hengli Tang. “This is a first step toward a therapeutic that can stop transmission of this disease.”
Tang, along with Johns Hopkins Professors Guo-Li Ming and Hongjun Song and National Institutes of Health scientist Wei Zheng identified two different groups of compounds that could potentially be used to treat Zika — one that stops the virus from replicating and the other that stops the virus from killing fetal brain cells, also called neuroprogenitor cells.
One of the identified compounds is the basis for a drug called Nicolsamide, a U.S. Food and Drug Administration approved drug that showed no danger to pregnant women in animal studies. It is commonly used to treat tapeworm.
This could be prescribed by a doctor today, though tests are still needed to determine a specific treatment regimen for the infection.
Their work is outlined in an article published Monday by Nature Medicine.
Though the Zika virus was discovered in 1947, there was little known about how it worked and its potential health implications — especially among pregnant women — until an outbreak occurred in South America last year. In the United States, there have been 529 cases of pregnant women contracting Zika, though most of those are travel related. As of Aug. 24, there have been 42 of locally transmitted cases in Florida.
The virus, among other diseases, can cause microcephaly in fetuses leading them to be born with severe birth defects.
“It’s so dramatic and irreversible,” Tang said. “The probability of Zika-induced microcephaly occurring doesn’t appear to be that high, but when it does, the damage is horrible.”
Researchers around the world have been feverishly working to better understand the disease — which can be transmitted both by mosquito bite and through a sexual partner — and also to develop medical treatments.
Tang, Ming and Song first met in graduate school 20 years ago and got in contact in January because Tang, a virologist, had access to the virus and Ming and Song, neurologists, had cortical stem cells that scientists needed to test.
The group worked at a breakneck pace with researchers from Ming and Song’s lab, traveling back and forth between Baltimore and Tang’s lab in Tallahassee where they had infected the cells with the virus.
In early March, the group was the first team to show that Zika indeed caused cellular phenotypes consistent with microcephaly, a severe birth defect where babies are born with a much smaller head and brain than normal.
They immediately delved into follow-up work and teamed with NIH’s Zheng, an expert on drug compounds, to find potential treatments for the disease.
Researchers screened 6,000 compounds that were either already approved by the FDA or were in the process of a clinical trial because they could be made more quickly available to people infected by Zika.
“It takes years if not decades to develop a new drug,” Song said. “In this sort of global health emergency, we don’t have time. So instead of using new drugs, we chose to screen existing drugs. In this way, we hope to create a therapy much more quickly.”
All of the researchers are continuing the work on the compounds and hope to begin testing the drugs on animals infected with Zika in the near future.
Learn more: FSU research team makes Zika drug breakthrough
The Latest on: Zika
via Google News
The Latest on: Zika
- Pitt Researchers: Previous Exposure To Dengue Fever Protects Against Zika on February 19, 2019 at 3:26 am
University of Pittsburgh researchers have found that previous exposure to Dengue Fever lowers the risk of infection from the Zika virus, which may have implications for maternal health. The study was ... […]
- Zika Virus Testing Market Set for Rapid Growth During by 2024 on February 18, 2019 at 9:51 am
Feb 18, 2019 (Heraldkeeper via COMTEX) -- New York, February 18, 2019: The scope of the report includes a detailed study of Zika Virus Testing Market with the reasons given for variations in the growt... […]
- Zika Vaccines Market Insights Shared in Detailed Report 2019 to 2025 on February 18, 2019 at 8:28 am
The report presents an in-depth assessment of the Zika Vaccines Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models ... […]
- Study of Brazil favela stricken by Zika shows dengue may protect against virus on February 17, 2019 at 11:00 pm
Infants born with microcephaly are held by mothers and family members at a meeting for mothers of children with special needs in Recife, Brazil. Photograph: Mario Tama/Getty Images Scientists studying ... […]
- New study uses small chip to immediately detect Zika, stage of infection on February 17, 2019 at 8:11 pm
SAN ANTONIO - A groundbreaking new study could soon take the guessing out of Zika treatment. The Texas Biomedical Research Institute in San Antonio is working with a team at the University of Californ... […]
- When Will We Have a Zika Vaccine? on February 14, 2019 at 10:17 am
You've probably heard by now that researchers are hard at work developing a vaccine against the Zika virus. Zika isn't a problem for most healthy adults (symptoms often resemble a mild flu and can inc... […]
- Zika Virus and Pregnancy: What You Need to Know Now on February 14, 2019 at 10:17 am
Zika virus can cause severe birth defects in babies whose mothers are infected during pregnancy, and it is now carried by mosquitos in the continental United States. However, while this means pregnant ... […]
- At epicenter of Zika outbreak, dengue immunity provided protection on February 7, 2019 at 1:53 pm
When the Zika virus arrived in the Americas in early 2015, it struck hard, infecting 73% of people in one Brazilian community at the epicenter of the pandemic, according to a new study led by the Yale ... […]
- Prior dengue infection may protect against Zika: study on February 7, 2019 at 11:29 am
CHICAGO (Reuters) - Prior infection with dengue, a mosquito-borne disease that infects nearly 400 million people a year, could reduce the risk of contracting Zika nearly by half, U.S. and Brazilian re... […]
- Dengue immunity may buffer against Zika, study finds on February 7, 2019 at 11:28 am
In the epicenter of the Zika epidemic in northeast Brazil, 73 percent of people living in an urban slum in Salvador were infected in 2015, but a new study finds that those with immunity to dengue, a g... […]
via Bing News